CSIMarket
 


Procyon Corporation  (PCYN)
Other Ticker:  
 
 

PCYN's Revenue Growth by Quarter and Year

Procyon's Revenue results by quarter and year




PCYN Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
IV Quarter June - 1.20 1.21 1.27
III Quarter March - 1.12 1.11 1.03
II Quarter December 1.20 1.18 1.33 1.17
I Quarter September 1.17 1.18 1.19 1.25
FY   2.37 4.68 4.84 4.72



PCYN Revenue second quarter 2024 Y/Y Growth Comment
Procyon Corporation reported Revenue growth of 1.7% year on year in the second quarter 2024, to $ 1.20 millions, this is lower than Procyon Corporation's recent average Revenue growth of 5.46%.

Looking into second quarter 2024 results within Major Pharmaceutical Preparations industry 43 other companies have achieved higher Revenue growth. While Procyon Corporation' s Revenue increase of 1.7% ranks overall at the positon no. 995 in the second quarter 2024.




PCYN Revenue ( Y/Y Growth %) 2024
2023 2022 2021
IV Quarter June - -0.83 % -4.72 % 44.32 %
III Quarter March - 0.9 % 7.77 % -9.65 %
II Quarter December 1.7 % -11.28 % 13.68 % 3.54 %
I Quarter September -0.85 % -0.84 % -4.8 % 5.93 %
FY   - -3.31 % 2.54 % 9.01 %

Financial Statements
Procyon's second quarter 2024 Revenue $ 1.20 millions PCYN's Income Statement
Procyon's second quarter 2023 Revenue $ 1.18 millions Quarterly PCYN's Income Statement
New: More PCYN's historic Revenue Growth >>


PCYN Revenue (Quarter on Quarter Growth %)

2024
2023 2022 2021
IV Quarter June - 7.14 % 9.01 % 23.3 %
III Quarter March - -5.08 % -16.54 % -11.97 %
II Quarter December 2.57 % 0 % 11.76 % -6.4 %
I Quarter September -2.5 % -2.48 % -6.3 % 42.05 %
FY (Year on Year)   - -3.31 % 2.54 % 9.01 %




Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #118
Overall #995

Revenue Y/Y Growth Statistics
High Average Low
25.33 % 5.46 % -10.09 %
(March 31, 2016)   (Dec. 30, 2014)
Revenue second quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #44
Healthcare Sector #118
Overall #995
Revenue Y/Y Growth Statistics
High Average Low
25.33 % 5.46 % -10.09 %
(March 31, 2016)   (Dec. 30, 2014)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Procyon's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
40.98 % 0.19 % -100 %
(Sep 30 2020)  


PCYN's II. Quarter Q/Q Revenue Comment
Procyon Corporation achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.57%, to $ 1.20 millions, from $1.17 millions in the first quarter.
Major Pharmaceutical Preparations company is impressively improving, with recording above regular growth, and also improving rate, Juan Jones, Major Pharmaceutical Preparations industry consultant situated in Houston mentioned.

Within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Procyon's Revenue growth quarter on quarter, overall rank is 607.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #85
Overall #607
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #28
Healthcare Sector #85
Overall #607
Revenue Q/Q Growth Statistics
High Average Low
40.98 % 0.19 % -100 %
(Sep 30 2020)  


PCYN's II. Quarter Q/Q Revenue Comment
Procyon Corporation achieved in the II. Quarter 2024 above company average sequential Revenue growth of 2.57%, to $ 1.20 millions, from $1.17 millions in the first quarter.
Procyon is going from strength to strength, with reporting better then regular increase, and additionally accelerating rate.

Within Major Pharmaceutical Preparations industry 27 other companies have achieved higher Revenue quarter on quarter growth. While Procyon's Revenue growth quarter on quarter, overall rank is 607.


Procyon's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2023)
12 Months Ending
(Sep 30 2023)
12 Months Ending
(Jun 30 2023)
12 Months Ending
(Mar 31 2023)
12 Months Ending
(Dec 31 2022)
Cumulative Revenue 12 Months Ending $ 4.70 $ 4.68 $ 4.69 $ 4.69 $ 4.68
Y / Y Revenue Growth (TTM) 0.4 % -2.98 % -3.22 % -4.18 % -2.87 %
Year on Year Revenue Growth Overall Ranking # 993 # 1690 # 2277 # 1372 # 1367
Seqeuential Revenue Change (TTM) 0.34 % -0.06 % -0.15 % 0.26 % -3.04 %
Seq. Revenue Growth (TTM) Overall Ranking # 995 # 1980 # 2571 # 2402 # 2431




Cumulative Revenue growth Comment
Although Procyon's Annual Revenue growth year on year were below company's average 5.46% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.4% year on year, from -2.98% in Sep 30 2023.

In the Healthcare sector 117 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 993, from total ranking in previous quarter at 1690.

Revenue TTM Q/Q Growth Statistics
High Average Low
25.33 %
5.46 %
-10.09 %
 

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 44
Healthcare Sector # 118
Overall # 993

Revenue TTM Y/Y Growth Statistics
High Average Low
25.33 %
5.46 %
-10.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 44
Sector # 118
S&P 500 # 995
Cumulative Revenue growth Comment
Although Procyon's Annual Revenue growth year on year were below company's average 5.46% , Revenue announced in the Dec 31 2023 period, show improvement in Revenue trend, to cumulative trailing twelve month growth of 0.4% year on year, from -2.98% in Sep 30 2023.

In the Healthcare sector 117 other companies have achieved higher trailing twelve month Revenue growth. While Total ranking has impoved so far to 993, from total ranking in previous quarter at 1690.

Revenue TTM Q/Q Growth Statistics
High Average Low
25.33 %
5.46 %
-10.09 %
 


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 44
Healthcare Sector # 118
Overall # 993

Revenue TTM Y/Y Growth Statistics
High Average Low
25.33 %
5.46 %
-10.09 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 44
Sector # 118
S&P 500 # 995




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
PCYN's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth
Revenue Growth for PCYN's Competitors
Revenue Growth for Procyon's Suppliers
Revenue Growth for PCYN's Customers

You may also want to know
PCYN's Annual Growth Rates PCYN's Profitability Ratios PCYN's Asset Turnover Ratio PCYN's Dividend Growth
PCYN's Roe PCYN's Valuation Ratios PCYN's Financial Strength Ratios PCYN's Dividend Payout Ratio
PCYN's Roa PCYN's Inventory Turnover Ratio PCYN's Growth Rates PCYN's Dividend Comparisons



Companies with similar Revenue growth for the quarter ending Dec 31 2023 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2023
Becton Dickinson And Company2.62%$ 2.617 millions
Cumberland Pharmaceuticals Inc2.51%$ 2.514 millions
Prestige Consumer Healthcare Inc 2.33%$ 2.328 millions
Sanofi2.32%$ 2.324 millions
Amneal Pharmaceuticals Inc 2.30%$ 2.298 millions
Teleflex Incorporated2.09%$ 2.094 millions
Taro Pharmaceutical Industries Ltd2.07%$ 2.070 millions
Phibro Animal Health Corporation2.03%$ 2.032 millions
Icu Medical Inc1.94%$ 1.940 millions
Koninklijke Philips Nv1.92%$ 1.918 millions
Akebia Therapeutics Inc 1.84%$ 1.838 millions
Amedisys Inc 1.55%$ 1.552 millions
Abbott Laboratories1.49%$ 1.486 millions
Procyon Corporation1.36%$ 1.361 millions
Harvard Bioscience Inc0.95%$ 0.946 millions




Help

About us

Advertise

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com